Epidemiology of Pecan Nut Allergy
PEC-ALL
Retrospective Study on Pecan Nut Allergy Epidemiology
1 other identifier
observational
50
1 country
1
Brief Summary
IgE-mediated food allergy can manifest with reactions ranging from hives to anaphylactic shock. The diagnosis is based on the confirmation of sensitization to the food allergen by skin tests (prick) and the determination of specific IgE directed against the food source and molecular allergens. The gold standard remains the oral provocation test, which is performed in a hospital environment. Once the diagnosis is made, an elimination diet is still considered as the cornerstone of treatment for most food allergies. While some allergies, such as cow's milk or egg, tend to resolve spontaneously, others, such as allergy to pecan nuts, show a tendency to be persistent. In addition, pecan allergy is often characterized by potentially serious clinical reactions, compared to other foods, which can even be life threatening. In our clinical practice, the investigators found that patients with allergies to pecan nuts often present with severe hypersensitivity reactions when challenged orally to this food. Beyond this information, there are few studies regarding pecans. The investigators decided to retrospectively evaluate the results of oral food challenge and of the allergy work-up in our patients sensitized and allergic to pecan nuts, to better understand the current epidemiology of such food allergy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJanuary 11, 2022
December 1, 2021
2 months
December 22, 2021
December 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of challenge-proven pecan allergy
Prevalence of challenge-proven pecan allergy in sensitized patients
day 1
Secondary Outcomes (2)
Epidemiological characteristics of pecan allergic patient
day 1
cut-off of specific IgE
day 1
Eligibility Criteria
Patients consulting in the Allergy Unit of the Arnaud de Villeneuve Hospital, sensitized to pecan nut, and having undergone an oral food challenge to this food allergen
You may qualify if:
- Patients assessed for pecan allergy, through oral food challenge, from January 2000 to december 2021, at the University Hospital of Montpellier
- Patients with a positive skin prick test and/or positive specific IgE to pecan nut
You may not qualify if:
- Patients not affiliated to French Social Security
- Patients not capable of understanding French
- Patients sensitized to pecan nut, who did not perform an oral food challenge to this food allergen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Davide CAIMMI
University Hospital, Montpellier
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
January 11, 2022
Study Start
November 1, 2021
Primary Completion
January 1, 2022
Study Completion
April 1, 2022
Last Updated
January 11, 2022
Record last verified: 2021-12